Tuberculosis Diagnostics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Tuberculosis Diagnostics Market to 2027 - Global Analysis and Forecasts By Type (Detection of Latent Infection, Radiography Method, Diagnostic Laboratory Methods, Cytokine Detection Assay, Detection of Drug Resistance, Nucleic Acid Testing and Other Methods); End user (Hospitals, Clinics, Reference Laboratories, Research Institutes and Academics and Others.)

Report Code: TIPRE00004210 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Tuberculosis or TB is an infectious disease caused by Mycobacterium tuberculosis bacteria that results in affecting mainly the lungs and other part of body.

MARKET DYNAMICS
The Tuberculosis Diagnostics market is anticipated to grow in the forecast period owing to driving factors such as increasing prevalence of tuberculosis, technological advancements, awareness about the importance of diagnosis, favorable initiatives taken by government, and accuracy of the tests. Nevertheless, limited accuracy and the more extended handling time is expected to restrict the market growth during the forecast period.

MARKET SCOPE
The "Global Tuberculosis Diagnostics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Tuberculosis Diagnostics market with detailed market segmentation by Type, End User and Geography. The global Tuberculosis Diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Tuberculosis Diagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Tuberculosis Diagnostics market is segmented on the basis of Type and End User. Based on Type the market is segmented into Detection of Latent Infection, Radiography Method, Diagnostic Laboratory Methods, Cytokine Detection Assay, Detection of Drug Resistance, Nucleic Acid Testing and Other Methods. Based on End user the market is segmented into Hospitals, Clinics, Reference Laboratories, Research Institutes and Academics and Others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Tuberculosis Diagnostics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Tuberculosis Diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Tuberculosis Diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Tuberculosis Diagnostics market in these regions.

MARKET PLAYERS
The reports cover key developments in the Tuberculosis Diagnostics Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Tuberculosis Diagnostics Market are anticipated to lucrative growth opportunities in the future with the rising demand for Tuberculosis Diagnostics in the global market. Below mentioned is the list of few companies engaged in the Tuberculosis Diagnostics market.

The report also includes the profiles of key Tuberculosis Diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Abbott
  • BD
  • BioMerieux SA
  • Cepheid
  • F. Hoffmann-La Roche AG
  • Hain Lifescience GmbH
  • Hologic Corporation
  • Qiagen
  • Siemens
  • Thermo Fisher Scientific Inc.,
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Tuberculosis Diagnostics Market - By Type
1.3.2 Tuberculosis Diagnostics Market - By End user
1.3.3 Tuberculosis Diagnostics Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. TUBERCULOSIS DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. TUBERCULOSIS DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. TUBERCULOSIS DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. TUBERCULOSIS DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. TUBERCULOSIS DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. TUBERCULOSIS DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. DETECTION OF LATENT INFECTION
7.3.1. Overview
7.3.2. Detection of Latent Infection Market Forecast and Analysis
7.4. RADIOGRAPHY METHOD
7.4.1. Overview
7.4.2. Radiography Method Market Forecast and Analysis
7.5. DIAGNOSTIC LABORATORY METHODS
7.5.1. Overview
7.5.2. Diagnostic Laboratory Methods Market Forecast and Analysis
7.6. CYTOKINE DETECTION ASSAY
7.6.1. Overview
7.6.2. Cytokine Detection Assay Market Forecast and Analysis
7.7. DETECTION OF DRUG RESISTANCE
7.7.1. Overview
7.7.2. Detection of Drug Resistance Market Forecast and Analysis
7.8. NUCLEIC ACID TESTING AND OTHER METHODS
7.8.1. Overview
7.8.2. Nucleic Acid Testing and Other Methods Market Forecast and Analysis
8. TUBERCULOSIS DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. REFERENCE LABORATORIES
8.5.1. Overview
8.5.2. Reference Laboratories Market Forecast and Analysis
8.6. RESEARCH INSTITUTES AND ACADEMICS AND OTHERS.
8.6.1. Overview
8.6.2. Research Institutes and Academics and Others. Market Forecast and Analysis
9. TUBERCULOSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Tuberculosis Diagnostics Market Overview
9.1.2 North America Tuberculosis Diagnostics Market Forecasts and Analysis
9.1.3 North America Tuberculosis Diagnostics Market Forecasts and Analysis - By Type
9.1.4 North America Tuberculosis Diagnostics Market Forecasts and Analysis - By End user
9.1.5 North America Tuberculosis Diagnostics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Tuberculosis Diagnostics Market
9.1.5.1.1 United States Tuberculosis Diagnostics Market by Type
9.1.5.1.2 United States Tuberculosis Diagnostics Market by End user
9.1.5.2 Canada Tuberculosis Diagnostics Market
9.1.5.2.1 Canada Tuberculosis Diagnostics Market by Type
9.1.5.2.2 Canada Tuberculosis Diagnostics Market by End user
9.1.5.3 Mexico Tuberculosis Diagnostics Market
9.1.5.3.1 Mexico Tuberculosis Diagnostics Market by Type
9.1.5.3.2 Mexico Tuberculosis Diagnostics Market by End user
9.1.5.4 US Tuberculosis Diagnostics Market
9.1.5.4.1 US Tuberculosis Diagnostics Market by Type
9.1.5.4.2 US Tuberculosis Diagnostics Market by End user
9.2. EUROPE
9.2.1 Europe Tuberculosis Diagnostics Market Overview
9.2.2 Europe Tuberculosis Diagnostics Market Forecasts and Analysis
9.2.3 Europe Tuberculosis Diagnostics Market Forecasts and Analysis - By Type
9.2.4 Europe Tuberculosis Diagnostics Market Forecasts and Analysis - By End user
9.2.5 Europe Tuberculosis Diagnostics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Tuberculosis Diagnostics Market
9.2.5.1.1 Germany Tuberculosis Diagnostics Market by Type
9.2.5.1.2 Germany Tuberculosis Diagnostics Market by End user
9.2.5.2 France Tuberculosis Diagnostics Market
9.2.5.2.1 France Tuberculosis Diagnostics Market by Type
9.2.5.2.2 France Tuberculosis Diagnostics Market by End user
9.2.5.3 Italy Tuberculosis Diagnostics Market
9.2.5.3.1 Italy Tuberculosis Diagnostics Market by Type
9.2.5.3.2 Italy Tuberculosis Diagnostics Market by End user
9.2.5.4 Spain Tuberculosis Diagnostics Market
9.2.5.4.1 Spain Tuberculosis Diagnostics Market by Type
9.2.5.4.2 Spain Tuberculosis Diagnostics Market by End user
9.2.5.5 United Kingdom Tuberculosis Diagnostics Market
9.2.5.5.1 United Kingdom Tuberculosis Diagnostics Market by Type
9.2.5.5.2 United Kingdom Tuberculosis Diagnostics Market by End user
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Tuberculosis Diagnostics Market Overview
9.3.2 Asia-Pacific Tuberculosis Diagnostics Market Forecasts and Analysis
9.3.3 Asia-Pacific Tuberculosis Diagnostics Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Tuberculosis Diagnostics Market Forecasts and Analysis - By End user
9.3.5 Asia-Pacific Tuberculosis Diagnostics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Tuberculosis Diagnostics Market
9.3.5.1.1 Australia Tuberculosis Diagnostics Market by Type
9.3.5.1.2 Australia Tuberculosis Diagnostics Market by End user
9.3.5.2 China Tuberculosis Diagnostics Market
9.3.5.2.1 China Tuberculosis Diagnostics Market by Type
9.3.5.2.2 China Tuberculosis Diagnostics Market by End user
9.3.5.3 India Tuberculosis Diagnostics Market
9.3.5.3.1 India Tuberculosis Diagnostics Market by Type
9.3.5.3.2 India Tuberculosis Diagnostics Market by End user
9.3.5.4 Japan Tuberculosis Diagnostics Market
9.3.5.4.1 Japan Tuberculosis Diagnostics Market by Type
9.3.5.4.2 Japan Tuberculosis Diagnostics Market by End user
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Tuberculosis Diagnostics Market Overview
9.4.2 Middle East and Africa Tuberculosis Diagnostics Market Forecasts and Analysis
9.4.3 Middle East and Africa Tuberculosis Diagnostics Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Tuberculosis Diagnostics Market Forecasts and Analysis - By End user
9.4.5 Middle East and Africa Tuberculosis Diagnostics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Tuberculosis Diagnostics Market
9.4.5.1.1 South Africa Tuberculosis Diagnostics Market by Type
9.4.5.1.2 South Africa Tuberculosis Diagnostics Market by End user
9.4.5.2 Saudi Arabia Tuberculosis Diagnostics Market
9.4.5.2.1 Saudi Arabia Tuberculosis Diagnostics Market by Type
9.4.5.2.2 Saudi Arabia Tuberculosis Diagnostics Market by End user
9.4.5.3 U.A.E Tuberculosis Diagnostics Market
9.4.5.3.1 U.A.E Tuberculosis Diagnostics Market by Type
9.4.5.3.2 U.A.E Tuberculosis Diagnostics Market by End user
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Tuberculosis Diagnostics Market Overview
9.5.2 South and Central America Tuberculosis Diagnostics Market Forecasts and Analysis
9.5.3 South and Central America Tuberculosis Diagnostics Market Forecasts and Analysis - By Type
9.5.4 South and Central America Tuberculosis Diagnostics Market Forecasts and Analysis - By End user
9.5.5 South and Central America Tuberculosis Diagnostics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Tuberculosis Diagnostics Market
9.5.5.1.1 Brazil Tuberculosis Diagnostics Market by Type
9.5.5.1.2 Brazil Tuberculosis Diagnostics Market by End user
9.5.5.2 Argentina Tuberculosis Diagnostics Market
9.5.5.2.1 Argentina Tuberculosis Diagnostics Market by Type
9.5.5.2.2 Argentina Tuberculosis Diagnostics Market by End user
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. TUBERCULOSIS DIAGNOSTICS MARKET, KEY COMPANY PROFILES
11.1. ABBOTT
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BD
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BIOMéRIEUX SA
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. CEPHEID
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. F. HOFFMANN-LA ROCHE AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. HAIN LIFESCIENCE GMBH
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. HOLOGIC CORPORATION
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. QIAGEN
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SIEMENS
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. THERMO FISHER SCIENTIFIC INC.,
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

- Abbott
- BD
- BioMerieux SA
- Cepheid
- F. Hoffmann-La Roche AG
- Hain Lifescience GmbH
- Hologic Corporation
- Qiagen
- Siemens
- Thermo Fisher Scientific Inc.,